From robbie.mcIntyrezg@moeller-profilsysteme.de  Wed Oct  5 01:46:10 2005
Return-Path: <robbie.mcIntyrezg@moeller-profilsysteme.de>
Received: from mx1.FreeBSD.org (mx1.freebsd.org [216.136.204.125])
	by hub.freebsd.org (Postfix) with ESMTP id 6680016A41F
	for <bug-followup@freebsd.org>; Wed,  5 Oct 2005 01:46:10 +0000 (GMT)
	(envelope-from robbie.mcIntyrezg@moeller-profilsysteme.de)
Received: from moireach.freeserve.co.uk (p54AF655A.dip.t-dialin.net [84.175.101.90])
	by mx1.FreeBSD.org (Postfix) with SMTP id 7036143D49
	for <bug-followup@freebsd.org>; Wed,  5 Oct 2005 01:46:01 +0000 (GMT)
	(envelope-from robbie.mcIntyrezg@moeller-profilsysteme.de)
Message-Id: <f4a401c5c94e$473c56d8$2125708c@moireach.freeserve.co.uk>
Date: Wed, 05 Oct 2005 02:42:33 +0100
From: "Robbie McIntyre" <robbie.mcIntyrezg@moeller-profilsysteme.de>
To: bug-followup@freebsd.org
Subject: There's Nothing Like a Hot PenmnySt0ck

>Number:         86918
>Category:       junk
>Synopsis:       There's Nothing Like a Hot PenmnySt0ck
>Confidential:   no
>Severity:       serious
>Priority:       medium
>Responsible:    gnats-admin
>State:          closed
>Quarter:        
>Keywords:       
>Date-Required:  
>Class:          sw-bug
>Submitter-Id:   current-users
>Arrival-Date:   Wed Oct 05 01:50:25 GMT 2005
>Closed-Date:    Wed Oct 05 08:47:12 GMT 2005
>Last-Modified:  Wed Oct 05 08:47:12 GMT 2005
>Originator:     
>Release:        
>Organization:
>Environment:
>Description:
 ATTENTION INVESTING PUBLIC
 
  
 
 ASCE . PK
 Recent Trading Range: $.80 - $.90
 Expected Trading Range: $1.50 - $2.00
 ASCE . PK
 
  
 BELLEVUE, WA. September 14, 2005 . Ascentia Biomedical Corporation (OTC Pink Sheets; ASCE), a leading researcher and developer of efficacious 
 pharmaceuticals, compounds and other products, announces it has received an initial commitment for up to $1 million in funding for continued research 
 particularly in anti-cancer compounds and for organizational growth.
 
 
 BELLEVUE, WA. September 27th, 2005 . Ascentia Biomedical Corporation (OTC Pink Sheets; ASCE), a leading researcher and developer of efficacious 
 pharmaceuticals, compounds and other products, announces the addition of Dr. Philip Mease to its Scientific Advisory Board. Dr. James Clagett, 
 President and CEO of Ascentia said, .We are privileged to have such an internationally recognized rheumatologist who has a distinguished career in the 
 clinical development of therapies for rheumatic diseases.  Dr. Mease.s experience in clinical drug discovery along with his respected relationship with 
 drug regulatory agencies will greatly assist Ascentia in its drug discovery and commercialization program..
 
 
 Dr. Mease is Chief of the Rheumatology Clinical Research Division at Swedish Hospital, Clinical Professor at the University of Washington, and founder 
 of Seattle Rheumatology Associates.  Dr. Mease graduated from Stanford University Medical School and completed his medical training at University of 
 Washington, Seattle.
 
  
 About Ascentia Biomedical Corporation
 
 Our focus is SOLUTIONS through RESEARCH and DISCOVERY. Ascentia is developing and commercializing new pharmaceutical and biomedical products for 
 application in a number of areas, including treatment for asthma, arthritis, psoriasis and cancer.  Initially, a majority of these products will be 
 secured through direct purchase or through licensing. As the Company grows and evolves, more products will be developed internally. Ascentia is focused 
 on therapies for cancer and diseases of inflammation.
 
 
 Forward-Looking Statements
 
  
 
 This release may contain forward-looking statements that involve risks
 
 and uncertainties. These statements do not constitute representations
 
 or promises. Rather, these statements express opinions, hopes and
 
 desires that may not be based on objective or factual criteria or
 
 measurable results. No one should rely on such statements for any
 
 purpose except as specifically stated
 
  
 
 To get taken off the list email NOSTK@Yahoo.com
 
>How-To-Repeat:
>Fix:
>Release-Note:
>Audit-Trail:
State-Changed-From-To: open->closed 
State-Changed-By: linimon 
State-Changed-When: Wed Oct 5 08:46:44 GMT 2005 
State-Changed-Why:  
and 'nothing' is probably what you stand to gain. 

http://www.freebsd.org/cgi/query-pr.cgi?pr=86918 
>Unformatted:
